OA02.06 A Phase II Trial of Poziotinib in EGFR and HER2 exon 20 Mutant Non-Small Cell Lung Cancer (NSCLC)

Details 詳細情報について

• CRID

  1361981469771374976

• DOI

  10.1016/j.jtho.2018.08.243

• ISSN

  15560864

• Web Site

  https://api.elsevier.com/content/article/PII:S1556086418312012?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1556086418312012?httpAccept=text/plain

• Data Source

  • Crossref